News
2016
company
year
domain
Editas Medicine Extends CRISPR Genome Editing Leadership Through Licensing of New CRISPR Technologies
Editas Medicine 12.19.2016
Immigrant Entrepreneurs: They Get the Job Done (via the Boston Business Journal)
Flagship Pioneering 12.02.2016
Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cells
11.25.2016
